Prevalencia de los marcadores de infección de los virus de las hepatitis en pacientes portadores del VIH en el sur de España
Tài liệu tham khảo
Alter, 2006, Epidemiology of viral hepatitis and HIV co-infection, J Hepatol, 44, S6, 10.1016/j.jhep.2005.11.004
Koziel, 2007, Viral hepatitis in HIV infection, N Engl J Med, 356, 1445, 10.1056/NEJMra065142
González-García, 2005, Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study, Enferm Infecc Microbiol Clin, 23, 340, 10.1157/13076173
Ramos, 2007, Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients, J Infect, 54, 173, 10.1016/j.jinf.2006.02.006
Pérez-Cachafeiro, 2009, Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006, Clin Infect Dis, 48, 1467, 10.1086/598333
Pineda, 2007, Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients, J Antimicrob Chemother, 60, 1347, 10.1093/jac/dkm373
Núñez, 2007, Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial, AIDS Res Hum Retroviruses, 23, 972, 10.1089/aid.2007.0011
Neukam, 2009, A review of current anti-HCV treatment regimens and possible future strategies, Expert Opin Pharmacother, 10, 417, 10.1517/14656560802694481
Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el estudio del Hígado (AEEH). Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus. Enferm Infecc Microbiol Clin. 2010;28:1–31.
Merchante, 2006, Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease, AIDS, 20, 49, 10.1097/01.aids.0000198087.47454.e1
Roca, 2003, Hepatitis C virus and human immunodeficiency virus coinfection in Spain, J Infect, 47, 117, 10.1016/S0163-4453(03)00067-7
Andreu, 1994, High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group, J Intern Med, 236, 73, 10.1111/j.1365-2796.1994.tb01122.x
Lissen, 1993, Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases, Eur J Clin Microbiol Infect Dis, 12, 827, 10.1007/BF02000402
Morales, 1993, Prevalence of antibodies against hepatitis C virus in a sample of homosexual males, Med Clin (Barc), 100, 50
Sánchez-Quijano, 1990, Hepatitis C virus infection in sexually promiscuous groups, Eur J Clin Microbiol Infect Dis, 9, 610, 10.1007/BF01967218
Rauch, 2005, Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV cohort study, Clin Infect Dis, 41, 395, 10.1086/431486
Van de Laar, 2007, Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission, J Infect Dis, 196, 230, 10.1086/518796
Van de Laar, 2010, Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection, AIDS, 24, 1799, 10.1097/QAD.0b013e32833c11a5
Berenguer, 2009, Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus, Hepatology, 50, 407, 10.1002/hep.23020
Mehta, 2005, A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users, AIDS, 19, S179, 10.1097/01.aids.0000192088.72055.90
Zinkernagel, 2006, Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study, Antivir Ther, 11, 131, 10.1177/135965350601100207
Medrano, 2011, Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients, J Viral Hepat, 18, 325, 10.1111/j.1365-2893.2010.01309.x
Salleras, 1992, A change in the epidemiologic pattern of hepatitis A in Spain, Med Clin, 99, 87